Cheng Zu

613 total citations
20 papers, 234 citations indexed

About

Cheng Zu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Cheng Zu has authored 20 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Cheng Zu's work include CAR-T cell therapy research (11 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Immunotherapy and Immune Responses (3 papers). Cheng Zu is often cited by papers focused on CAR-T cell therapy research (11 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Immunotherapy and Immune Responses (3 papers). Cheng Zu collaborates with scholars based in China and United States. Cheng Zu's co-authors include Chen‐Yu Zhang, Yong Zhou, Hui‐Hui Yang, Cha‐Xiang Guan, He Huang, Jia‐Xi Duan, Yongxian Hu, Xinxin Guan, Chen‐Chen Sun and Jian‐Bing Xiong and has published in prestigious journals such as Frontiers in Immunology, Journal of Cellular Physiology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Cheng Zu

19 papers receiving 230 citations

Peers

Cheng Zu
Megan L. Sulciner United States
Jarosław Szefel Poland
Sandy Ferber United States
Benjamin Kühn United States
Ahmad Goodarzi United States
Lin Guan China
Johnson H.Y. Yip Hong Kong
Yanan Ming China
Huyen Nguyen United States
Megan L. Sulciner United States
Cheng Zu
Citations per year, relative to Cheng Zu Cheng Zu (= 1×) peers Megan L. Sulciner

Countries citing papers authored by Cheng Zu

Since Specialization
Citations

This map shows the geographic impact of Cheng Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Zu more than expected).

Fields of papers citing papers by Cheng Zu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Zu. The network helps show where Cheng Zu may publish in the future.

Co-authorship network of co-authors of Cheng Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Zu. A scholar is included among the top collaborators of Cheng Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Zu. Cheng Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Rong, Zhiyu Zhang, Shijie Zhang, et al.. (2025). TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity. npj Vaccines. 10(1). 13–13. 4 indexed citations
2.
3.
Ning, Kang, Yuanfei Zhu, Hanqing Wang, et al.. (2024). Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics. Acta Biochimica et Biophysica Sinica. 56(7). 986–996. 1 indexed citations
4.
Zu, Cheng, et al.. (2024). Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies. BMC Infectious Diseases. 24(1). 1147–1147.
5.
6.
Fu, Shan, Qiqi Zhang, Ruirui Jing, et al.. (2023). HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy. Bone Marrow Transplantation. 58(6). 701–709. 10 indexed citations
7.
8.
9.
10.
Xu, Xueer, Cheng Zu, Mingming Zhang, et al.. (2023). HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma. Cell Transplantation. 32. 4231252121–4231252121. 3 indexed citations
11.
Zhang, Qiqi, et al.. (2022). Risk factors of tumor lysis syndrome in relapsed/refractory multiple myeloma patients undergoing BCMA CAR-T cell therapy. Journal of Zhejiang University (Medical Sciences). 51(2). 144–150. 3 indexed citations
12.
Liu, Tian, Chen‐Yu Zhang, Cheng Zu, et al.. (2022). Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF‐β1‐Smad2/3 Signaling in a PPARγ‐Dependent Manner. Oxidative Medicine and Cellular Longevity. 2022(1). 7265486–7265486. 14 indexed citations
13.
Zu, Cheng, Kexin Wang, Qiqi Zhang, Yongxian Hu, & He Huang. (2022). Clinical features of hemophagocytic syndrome following BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma. Journal of Zhejiang University (Medical Sciences). 51(2). 160–166. 7 indexed citations
14.
Zu, Cheng, Fang Ni, Zhe Yang, et al.. (2022). Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement. Regenerative Therapy. 21. 34–36. 4 indexed citations
15.
Zu, Cheng, Yufeng Xu, Yiyun Wang, et al.. (2022). Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Current Oncology. 29(2). 490–496. 13 indexed citations
16.
Zhang, Qiqi, Cheng Zu, Yongxian Hu, & He Huang. (2022). CAR-T cells for cancer immunotherapy—the barriers ahead and the paths through. International Reviews of Immunology. 41(6). 567–581. 1 indexed citations
17.
Duan, Jia‐Xi, Huiling Jiang, Xinxin Guan, et al.. (2021). Extracellular citrate serves as a DAMP to activate macrophages and promote LPS-induced lung injury in mice. International Immunopharmacology. 101(Pt B). 108372–108372. 18 indexed citations
18.
Wang, Yiyun, Linqin Wang, Yifan Zeng, et al.. (2021). Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission. Frontiers in Oncology. 11. 755584–755584. 6 indexed citations
19.
Zhang, Yanfeng, Chen‐Chen Sun, Jia‐Xi Duan, et al.. (2020). A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress. Biomedicine & Pharmacotherapy. 126. 109907–109907. 45 indexed citations
20.
Luo, Xiaoqin, Jia‐Xi Duan, Hui‐Hui Yang, et al.. (2020). Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages. Journal of Cellular Physiology. 235(12). 9910–9921. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Megan L. Sulciner Breakdown of academic impact, for papers by Jarosław Szefel Breakdown of academic impact, for papers by Sandy Ferber Breakdown of academic impact, for papers by Benjamin Kühn Breakdown of academic impact, for papers by Ahmad Goodarzi Breakdown of academic impact, for papers by Lin Guan Breakdown of academic impact, for papers by Johnson H.Y. Yip Breakdown of academic impact, for papers by Yanan Ming Breakdown of academic impact, for papers by Huyen Nguyen
Rankless by CCL
2026